Search

everythinglearnresearchcommunity

for

Search:↓

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Yak hair growth is influenced by genes and hormones, helping them adapt to alpine environments.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Hair loss caused by genetics and hormones; more research needed for treatments.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

GLP-1 RAs may help wound healing but can also cause faster facial aging and skin issues.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

The vitamin D receptor can act without its usual activating molecule, affecting hair growth and skin cancer, but its full range of actions is not well understood.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.